Home / GRIN3B Knockout Cell Lines

GRIN3B Knockout Cell Lines

Gene: GRIN3B

Official Full Name: glutamate ionotropic receptor NMDA type subunit 3Bprovided by HGNC

Gene Summary: The protein encoded by this gene is a subunit of an N-methyl-D-aspartate (NMDA) receptor. The encoded protein is found primarily in motor neurons, where it forms a heterotetramer with GRIN1 to create an excitatory glycine receptor. Variations in this gene have been proposed to be linked to schizophrenia. [provided by RefSeq, Nov 2015]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO07555 GRIN3B Knockout cell line (HEK293) Human GRIN3B 1:3~1:6 Negative Online Inquiry

Background

GRIN3B Gene Knockout Cell Lines are genetically engineered cellular systems designed to silence the GRIN3B gene, which encodes for a subunit of the NMDA receptor. By utilizing CRISPR-Cas9 gene-editing technology, these cell lines have been specifically modified to elucidate the functional roles of GRIN3B in neuronal signaling and plasticity. The knockout mechanism efficiently disrupts the expression of the GRIN3B gene, subsequently enabling researchers to observe the physiological changes in cellular behavior, synaptic transmission, and neurodevelopmental processes.

The scientific importance of GRIN3B gene knockout cell lines extends into both basic and applied research realms. They serve as invaluable tools for studying the implications of NMDA receptor dysregulation in neurological conditions such as schizophrenia, Alzheimer's disease, and epilepsy. Furthermore, these cell lines facilitate the investigation of therapeutic strategies aimed at modulating NMDA receptor activity, thereby providing potential pathways for drug development and gene therapy.

One of the standout technologies that sets GRIN3B gene knockout cell lines apart from alternative options is the precision with which they are constructed, leading to highly reproducible and consistent results. Unlike traditional methods of gene silencing, such as siRNA or antisense oligonucleotides, which may have off-target effects or transiently reduce gene expression, the CRISPR-Cas9 technique allows for a permanent knockout of the gene, thus providing a more stable model for long-term studies.

For researchers and clinicians, the value of GRIN3B gene knockout cell lines lies not only in their ability to deliver reliable insights into the physiological roles of GRIN3B but also in their potential to advance novel therapeutic interventions. Leveraging these cellular models can significantly accelerate the understanding of complex neurobiological mechanisms and enhance the translation of research findings into clinical applications.

With a commitment to advancing genetic research, our company specializes in offering high-quality, customizable genetically engineered cell lines, supported by a team of experts dedicated to ensuring the integrity and applicability of our products in the ever-evolving landscape of biological sciences.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.